HIV policy: The path forward- A joint position paper of the HIV medicine association of the infectious diseases society of America and the American College of physicians

Clinical Infectious Diseases

Volumn 48, Issue 10, 2009, Pages 1335-1344

  Lubinski, Christine ^a   Aberg, Judith ^a,d   Bardeguez, Arlene D ^a,e   Ellon, Richard ^a,f   Emmanuel, Patricia ^a,h   Kuritzkes, Daniel ^a,i   Saag, Michael ^a,j   Squires, Kathleen E ^a,k   Weddle, Andrea ^a   Rainey, Jennifer ^a   Zerehi, M Renee ^g   Ralston, J Fred ^g,m   Fleming, David A ^g,n   Bronson, David ^g,o   Cooke, Molly ^g,l   Cutler, Charles ^g   Ejnes, Yul ^g,p   Gluckman, Robert ^g,q   Liebow, Mark ^g,r   Musana, Kenneth ^c,g   Mayer, Mark E ^g,o   Purtle, Mark W ^g,s   Reynolds, P Preston ^b,g   Viswanathan, Lavanya ^g,v   Weiss, Kevin B ^g,t   Yehia, Baligh ^g,u   more..

^a Infectious Diseases Society of America Emerging Infections Network   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d BELLEVUE HOSPITAL CENTER   (United States)

^e RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^f Elizabeth Taylor Medical Center   (United States)

^g AMERICAN COLLEGE OF PHYSICIANS   (United States)

^h UNIVERSITY OF SOUTH FLORIDA   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k THOMAS JEFFERSON UNIVERSITY   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m Fayetteville Medical Associates   (United States)

ⁿ University of Missouri   (United States)

^o LERNER RESEARCH INSTITUTE   (United States)

^p Department of Pharmacy   (United States)

^q Graduate Medical Education   (United States)

^r MAYO CLINIC   (United States)

^s Central Iowa Hospital Corporation   (United States)

^t American Board of Medical Specialists   (United States)

^u JOHNS HOPKINS UNIVERSITY   (United States)

^v UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL RESISTANCE; CLINICAL MEDICINE; CLINICAL PRACTICE; COMORBIDITY; DEVELOPING COUNTRY; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; FUNDING; GOVERNMENT; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; MALARIA; MEDICAL SOCIETY; MONONUCLEOSIS; MONOTHERAPY; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; REVIEW; SCREENING; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; VIRUS TRANSMISSION; ARTICLE; CASE MANAGEMENT; PRACTICE GUIDELINE; UNITED STATES;

CASE MANAGEMENT; HIV INFECTIONS; HUMANS; UNITED STATES;

EID: 65549133220     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598169     Document Type: Review

References (77)

1. Acquired immunodeficiency syndrome. Health and Public Policy Committee, American College of Physicians; and the Infectious Diseases Society of America. Ann Intern Med 1986;104:575-81.
2. Health and Public Policy Committee, American College of Physicians; and the Infectious Diseases Society of America. The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency syndrome (HIV). Ann Intern Med 1988;108:460-9.
3. Health and Public Policy Committee, American College of Physicians; and the Infectious Diseases Society of America. Human immunodeficiency virus (HIV) infection. Ann Intern Med 1994;120:310-9.
4. Walensky R, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis 2006;194:11-9.
5. Kaiser Family Foundation. HIV/AIDS policy fact sheet: the HIV/AIDS epidemic in the United States, July 2007. Available at: http://www.kff.org/ hivaids/upload/3029-071.pdf. Accessed 20 March 2009.
6. Centers for Disease Control and Prevention. HIV/AIDS surveillance report: cases ofHIV infection and AIDS in the United States and dependent areas, 2005. Atlanta, GA: Centers for Disease Control and Prevention, 2005. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/pdf/ 2005SurveillanceReport.pdf. Accessed 20 March 2009.
7. Glynn M, Rhodes P. Estimated HIV prevalence in the United States at the end of 2003 [abstract T1-B1101]. In: Program and abstracts of the National HIV Prevention Conference (Atlanta). 2005.
8. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008;300:520-9.
9. Centers for Disease Control and Prevention. Estimates of new HIV infections in the United States: CDC HIV/AIDS facts, August 2008. Atlanta, GA: Centers for Disease Control and Prevention, 2008. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/factsheets/pdf/incidence. pdf. Accessed 20 March 2009.
10. Centers for Disease Control and Prevention. CDC HIV/AIDS factsheet: HIV/AIDS among women, revised June 2007. Available at: http://www.cdc.gov/hiv/ topics/women/resources/factsheets/pdf/women.pdf. Accessed 20 March 2009.
11. National Center for Health Statistics. Health, United States, 2004 with chartbook on trends in the health of Americans. Hyattsville, Maryland: National Center for Health Statistics, 2004.
12. Grubman S, Gross E, Lerner-Weiss N, et al. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics 1995;95:657-63.
13. Lee LM, Karon JM, Selik R, et al. Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. JAMA 2001;285:1308-5.
14. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2008 Report on the global AIDS epidemic. Available at: http://www.unaids.org/en/KnowledgeCentre/ HIVData/GlobalReport/2008/. Accessed 13 March 2009.
15. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005;40:458-65.
16. McKenna M, Hu X. Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States. Am J Obstet Gynecol 2007;197(3 Suppl):S10-6.
17. Tai J, Udoji MA, Barkanic G, et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis 2007;196:1044-52.
18. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 2008;1-139. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf/. Accessed 13 March 2009.
19. National Institutes of Health, National Institutes of Allergy and Infectious Diseases. Treatment of HIV infection, November 2007. Available at: http://www.niaid.nih.gov/factsheets/treat-hiv.htm. Accessed 20 March 2009.
20. World Health Organiztion. Frequently asked questions about TB and HIV. Available at: http://www.who.int/tb/hiv/faq. Accessed 13 March 2009.
21. Centers for Disease Control and Prevention. Trends in HIV/AIDS di-agnoses-33 States, 2001-2004. MMWRMorb Mortal Wkly Rep 2005;54:1149- 53.
22. Chen RY, Accortt NA, Westfall AO, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis 2006;42:1003-10.
23. Centers for Disease Control and Prevention. Update to racial/ethnic disparities in diagnoses of HIV/AIDS-33 States, 2001-2005. MMWRMorb Mortal Wkly Rep 2007;56:189-93.
24. Brenner BG, Roger M, Routy JP, et al. High rates offorward transmission events after acute/early HIV-1 infection. J Infect Dis 2007;195:951-9.
25. Kates J. Financing HIV/AIDS care: a quilt with many holes. Washington, DC: Kaiser Family Foundation, 2004.
26. Kinsler JJ, Wong MD, Sayles JN, Davis C, Cunningham WE. The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. AIDS Patient Care STDS 2007;21:584- 92.
27. Bogart LM, Cowgill BO, Kennedy D, et al. HIV-related stigma among people with HIV and their families: a quality analysis. AIDS Behav 2008;12:244- 54.
28. Vanable PA, Carey MP, Blair DC, Littlewood RA. Impact ofHIV-related stigma on health behaviors and psychological adjustment among HIV- positive men and women. AIDS Behav 2006;10:473-82.
29. USA: Cirque du Soleil pays US "600,000 to end HIV discrimination complaint. Can HIV AIDS Policy Law Rev 2004;9:36.
30. Brooks RA, Martin DJ, Ortiz DJ, Veniegas RC. Perceived barriers to employment among persons living with HIV/AIDS. AIDS Care 2004;16:756-66.
31. Kaiser Family Foundation. Survey of Americans on HIV/AIDS: part three-experiences and opinions by race/ethnicity and age, August 2004. Menlo Park, CA: Kaiser Family Foundation, 2004. Available at: http://www.kff.org/hivaids/upload/Survey-of-Americans-on-HIV-AIDS-Part-Three- Experiences-and-Opinions-by-Race-Ethnicity-and-Age.pdf. Accessed 20 March 2009.
32. Schuster MA, Collins R, Cunningham WE, et al. Perceived discrimination in clinical care in a nationally representative sample of HIV- infected adults receiving health care. J Gen Intern Med 2005;20:807-13.
33. Rangel MC, Gavin L, Reed C, Fowler MG, Lee LM. Epidemiology of HIV and AIDS among adolescents and young adults in the United States. J Adolesc Health 2006;39:156-63.
34. Grant AM, Jamieson DJ, Elam-Evans LD, et al. Reason for testing and clinical and demographic profile of adolescents with non-perinatally acquired HIV infection. Pediatrics 2006;117:e468-75.
35. Murphy D, et al, Factors associated with HIV testing among HIV- positive and HIV-negative high risk adolescents: the REACH study. Pediatrics 2002;110:e36.
36. Section 510(b) of Title V of the Social Security Act, P.L. 104-193.
37. US Department of Health and Human Services, Administration for children and families. Community-based abstinence education. Available at: http://www.acf.hhs.gov/programs/fysb/content/abstinence/index.htm. Accessed 13 March 2009.
38. Adolescent Family Life Act. 42 U.S. C. 300Z.
39. United States House of Representatives, Committee on Government Reform-Minority Staff, Special Investigations Division, December 2004. The content of Federally funded abstinence-only education programs. Available at: http://oversight.house.gov/documents/20041201102153-50247.pdf. Accessed 20 March 2009.
40. Underhill K, Montgomery P, Operario D. Sexual abstinence only programmes to prevent HIV infection in high income countries: systematic review. Br Med J 2007;335:248.
41. Office of the Surgeon General. Evidence-based findings on the efficacy of syringe exchange programs: an analysis from the Assistant Secretary for Health and the Surgeon General of the scientific research completed since April 1998. Washington, DC: Office of the Surgeon General, 2000.
42. Holtgrave DR, Pinkerton SD, Jones TS, Lurie P, Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. J Acquir Immune Defic Syndr Hum Retroviral 1998;18(Suppl 1):S133-8.
43. National Institute on Drug Abuse. Principles of HIV prevention in drug-using populations: a research-based guide. National Institutes of Health Publication no. 02-4733. March 2002.
44. Centers for Disease Control and Prevention. Basic statistics: HIV/AIDS cases by transmission category. Available at: http://www.cdc.gov/hiv/topics/ surveillance/basic.htm. Accessed 13 March 2009.
45. Consolidated Appropriations Act, 2008. PL-110-161.26 December 2007.
46. Branson BM, Handsfield HH, Lampe MA, et al.; Centers for Disease Control and Prevention; Department of Health and Human Services. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings. MMWR Recomm Rep 2006;55(RR-14):1-17; quiz CE1-4.
47. Centers for Disease Control and Prevention; Department of Health and Human Services. Heightened national response to the HIV/AIDS crisis among African Americans: presentation from the 2008 HIV Leadership Summit. Atlanta, GA: Centers for Disease Control and Prevention, 2007. Available at: http://www.cdc.gov/HIV/topics/aa/resources/slidesets/hpls-cleveland.htm. Accessed 20 March 2009.
48. Centers for Disease Control and Prevention; Health Resources and Services Administration; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Incorporating HIV prevention into the Medicare care of persons living with HIV. Recommendations of Centers for Disease Control and Prevention, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2003;52(RR12);1- 24.
49. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:329-32. Available at: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm5215a1.htm. Accessed 20 March 2009.
50. Centers for Disease Control and Prevention; Department of Health and Human Services. Comprehensive HIV prevention: essential components of a comprehensive strategy to prevent domestic HIV. Atlanta, GA: Centers for Disease Control and Prevention, 2006. Available at: http://www.cdc.gov/hiv/ resources/reports/comp-hiv-prev/pdf/comp-hiv-prev.pdf. Accessed 20 March 2009.
51. Stolte IG, de Wit JB, van Eeden A, Coutinho RA, Dukers NH. Perceived viral load, but not actual HIV-1-RNA load, is associated with sexual risk behavior among HIV-infected homosexual men. AIDS 2004;18:1943-9.
52. Ciccarone DH, Kanouse DE, Collins RL, et al. Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection. Am J Pub Health 2003;93:949-54.
53. AIDSInfo Web page. Available at: http://www.aidsinfo.nih.gov. Accessed 13 March 2009.
54. Kitihata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med 1996;334:701-6.
55. Mitchell TF, Brosgart CL, Dyner T. Community patterns ofcare for HIV disease: experience makes a difference [abstract 255]. In: Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections (Washington DC), 22-26 January 1998.
56. Blumenthal D, Gokhale M, Campbell EG, Weissman JS. Preparedness for clinical practice: reports of graduating residents at academic health centers. JAMA 2001;286:1027-34.
57. Lubinski C. HIV medical workforce overview and preliminary results from the HIVMA Ryan White part C survey. In: Program and abstracts of the HRSA/HIV/AIDS Bureau HIV/AIDS Workforce Meeting (Rock- ville, MD). 2008.
58. Association of American Medical Colleges. Diversity in the physician workforce: facts and figures, 2006. Available at: http://www.aamc.org/ factsandfigures. Accessed 13 March 2009.
59. Institute of Medicine. Unequal treatment: what healthcare providers need to know about racial and ethnic disparities in healthcare. Washington, DC: Board on Health Sciences Policy, 2002.
60. Cooper LA, roter DL, Johnson RL, Ford DE, Steinwachs DM, Powe NR. Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med 2003;139:907-15.
61. King WD, Wong MD, Shapiro MF, Landon BE, Cunningham WE. Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors? J Gen Intern Med 2004;19:1146-53.
62. Kaiser Family Foundation. US Federal funding for HIV/AIDS: the FY 2009 budget request. Menlo Park, CA: Kaiser Family Foundation, 2008.
63. Institute of Medicine of the National Academy of Sciences, Board on Health Promotion and Disease Prevention. Public financing and delivery of HIV/AIDS care: securing the legacy of Ryan White. Washington, DC: National Academy of Sciences, 2004.
64. Kates J, Carbaugh AL. National ADAP monitoring project: annual report 2007. Washington, DC: Kaiser Family Foundation, 2007. Available at: http://www.nastad.org/Docs/highlight/2008523-2007727- 2007NationalADAPMonitoringRepFINAL.pdf. Accessed 20 March 2009.
65. Continuing Appropriations Resolution. Pub, L. no. 110-5. Division B. Congressional Record vol. 153. 2007.
66. Kahn J, Haile B, Kates, J, Chang S. Health and federal budgetary effects on increasing access to antiretroviral medications for HIV by expanding Medicaid. Am J Pub Health 2001;91:1464-73.
67. Westmoreland T. Medicaid and HIV/AIDS policy: a basic primer. Menlo Park, CA: Kaiser Family Foundation, 1999.
68. Early treatment for HIV act of 2007 (S860/HR3326). Available at: http://thomas.loc.gov/cgi-bin/query/z?c110:s860. Accessed 20 March 2009.
69. Gielen AC, O'Campo P, Faden RR, Eke A. Women's disclosure of HIV status: experiences of mistreatment and violence in an urban setting. Womens Health 1997;25:19-31.
70. Maher JE, Peterson J, Hastings K, et al. Partner violence, partner notification, and women's decisions to have an HIV test. J Acquir Immune Defic Syndr 2000;25:276-82.
71. Centers for Disease Control and Prevention. HIV partner counseling and referral services: guidance. 30 December 1998. Available at: http://www.cdc.gov/hiv/resources/guidelines/pcrs/pdf/pcrs.pdf. Accessed 20 March 2009.
72. National Institutes of Health (NIH), US Department of Health and Human Services, Office of AIDS Research. NIH fiscal year 2010 trans- NIH plan for HIV-related research. Available at: http://www.oar.nih.gov/strategicplan/fy2010/ . Accessed 20 March 2009.
73. Department of Health and Human Services, National Institutes of Health, Office of AIDS Research (OAR). OAR FY 2008 Congressional budget justification. Available at: http://www.oar.nih.gov/budget/fy08justification.asp. Accessed 20 March 2009.
74. Whitescarver J. FY 2009 Congressional testimony to the House Subcommittee on Labor-HHS-Education Appropriations. Available at: http://www.oar.nih.gov/ budget/fy09testimony.asp. Accessed 13 March 2009.
75. United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003, P.L. 108-25. 27 May 2003. Available at: http://frwebgate.access.gpo. gov/cgi-bin/getdoc.cgi?dbname = 108-cong-public-laws& docid = f:publ025.108.pdf. Accessed 20 March 2009.
76. United States President's emergency plan for AIDS relief Web page. The power of partnerships: latest PEPFAR results (June 2008). Available at: http://www.pepfar.gov/press/fifth-annual-report/113728.htm.
77. The Tom Lantos and HenryJ. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008, P. L. 110-293 July 2008. Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi? dbname = 110-cong-bills&docid = f:h5501enr.txt.pdf.